HomeCompareXXIA vs VYM

XXIA vs VYM: Dividend Comparison 2026

XXIA yields 10.18% · VYM yields 2.37%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XXIA wins by $11.4K in total portfolio value
10 years
XXIA
XXIA
● Live price
10.18%
Share price
$19.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.2K
Annual income
$1,928.71
Full XXIA calculator →
VYM
Vanguard High Dividend Yield ETF
● Live price
2.37%
Share price
$148.10
Annual div
$3.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$272.94
Full VYM calculator →

Portfolio growth — XXIA vs VYM

📍 XXIA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXXIAVYM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XXIA + VYM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XXIA pays
VYM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XXIA
Annual income on $10K today (after 15% tax)
$865.14/yr
After 10yr DRIP, annual income (after tax)
$1,639.40/yr
VYM
Annual income on $10K today (after 15% tax)
$201.60/yr
After 10yr DRIP, annual income (after tax)
$232.00/yr
At 15% tax rate, XXIA beats the other by $1,407.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XXIA + VYM for your $10,000?

XXIA: 50%VYM: 50%
100% VYM50/50100% XXIA
Portfolio after 10yr
$33.5K
Annual income
$1,100.82/yr
Blended yield
3.29%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XXIA buys
0
VYM buys
0
No recent congressional trades found for XXIA or VYM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXXIAVYM
Forward yield10.18%2.37%
Annual dividend / share$2.00$3.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$39.2K$27.8K
Annual income after 10y$1,928.71$272.94
Total dividends collected$14.7K$2.6K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: XXIA vs VYM ($10,000, DRIP)

YearXXIA PortfolioXXIA Income/yrVYM PortfolioVYM Income/yrGap
1← crossover$11,718$1,017.81$11,147$237.17+$571.00XXIA
2$13,653$1,114.63$12,404$242.33+$1.2KXXIA
3$15,822$1,213.72$13,780$247.16+$2.0KXXIA
4$18,244$1,314.56$15,285$251.67+$3.0KXXIA
5$20,938$1,416.63$16,932$255.88+$4.0KXXIA
6$23,923$1,519.44$18,733$259.81+$5.2KXXIA
7$27,220$1,622.49$20,701$263.46+$6.5KXXIA
8$30,851$1,725.32$22,852$266.86+$8.0KXXIA
9$34,838$1,827.53$25,201$270.01+$9.6KXXIA
10$39,205$1,928.71$27,768$272.94+$11.4KXXIA

XXIA vs VYM: Complete Analysis 2026

XXIAStock

XXIA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in XXIA shares.

Full XXIA Calculator →

VYMETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →
📬

Get this XXIA vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XXIA vs SCHDXXIA vs JEPIXXIA vs OXXIA vs KOXXIA vs MAINXXIA vs VIGXXIA vs DGROXXIA vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.